Evidence map›Paper›PMID 22323172›Full record

ArticleHealth affairs (Project Hope)2012

The financial burden from prescription drugs has declined recently for the nonelderly, although it is still high for many.

Walid F Gellad, Julie M Donohue, Xinhua Zhao, Yuting Zhang, Jessica S Banthin

Abstract read
In one paragraph

Article in Health affairs (Project Hope), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Walid F GelladPittsburgh Veterans Affairs (VA) Medical Center, Pittsburgh, Pennsylvania, USA. wfg3@pitt.edu
Julie M Donohue
Xinhua Zhao
Yuting Zhang
Jessica S Banthin

Funding

UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
RESEARCH METHODS COREP30MH090333 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEW, MARY AMANDA · 2011 to 2015
$8.3M
Comparing Methods to Pay for Psychotropic Medications for Medicare BeneficiariesRC1MH088510 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZHANG, YUTING · 2009 to 2010
$912k
Racial and Ethnic Differences in Response to the Medicare Coverage Gap among PatiR01HS018657 · AHRQ · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZHANG, YUTING · 2010 to 2012
$676k
Impact of Medicare Part D on Racial Disparities in Diabetes Treatment and OutcomeR01HS017695 · AHRQ · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DONOHUE, JULIE MARIE · 2009 to 2011
$628k
Medicare Part D Cost-Sharing and Treatment of Mental Disorders Among Disabled DuaR34MH082682 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DONOHUE, JULIE MARIE · 2009 to 2010
$379k
AHRQ HHS 1R01HS017695AHRQ HHS R01 HS017695AHRQ HHS R01 HS018657HSRD VA CDA 09-207NCATS NIH HHS UL1 TR000005NCRR NIH HHS UL1 RR024153NIMH NIH HHS 1R34 MH082682NIMH NIH HHS P30 MH090333NIMH NIH HHS R34 MH082682NIMH NIH HHS RC1 MH088510
6 · The paper itself

Abstract

Prescription drug spending and pharmacy benefit design have changed greatly over the past decade. However, little is known about the financial impact these changes have had on consumers. We examined ten years of nationally representative data from the Medical Expenditure Panel Survey and describe trends in two measures of financial burden for prescription drugs: out-of-pocket drug costs as a function of family income and the proportion of all out-of-pocket health care expenses accounted for by drugs. We found that although the percentage of people with high financial burden for prescription drugs increased from 1999 to 2003, it decreased from 2003 to 2007, with a slight increase in 2008. The decline is evidence of the success of strategies to lower drug costs for consumers, including the increased use of generic drugs. However, the financial burden is still high among some groups, notably those with public insurance and those with low incomes. For example, one in four nonelderly people devote more than half of their total out-of-pocket health care spending to prescription drugs. These trends suggest that the affordability of prescription drugs under the future insurance exchanges will need to be monitored, as will efforts by states to increase prescription drug copayments under Medicaid or otherwise restrict drug use to reduce public spending.

Indexed as

Financing, PersonalHealth Care SurveysHealth ExpendituresHumansMiddle AgedPharmaceutical PreparationsUnited StatesPharmaceutical Preparations

Identifiers

PMID22323172
PMCPMC3387787

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.